described the ameliorating effect of hepatic disease on rheumatoid arthritis. Although jaundice was thought to be the determining factor in these remissions, it was not possible to reproduce the phenomenon by administration of bilirubin and bile salts (Hench, 1940) , and a satisfactory explanation of its mechanism has never been offered (Hill and Holley, 1966) . This was investigated in the present study using the rat adjuvant arthritis (AA) model.
With the hepatotoxin dimethylnitrosamine (DMN), it is possible to produce a necrotizing hepatitis, which resolves rapidly, resulting in a virtually normal histological appearance in about 2 weeks (Barnes and Magee, 1954) . Since DMN is converted by the action of liver enzymes to an alkylating intermediate which, in turn, is rapidly inactivated, it functions as a selective hepatotoxin (Magee and Swann, 1969) . Thus a brief but severe episode of liver injury may be superimposed on AA at various points during its induction and course.
Material and methods Male Carworth rats weighing 120 to 175 g. were injected in the tail with 0-1 ml. complete Freund's adjuvant, M. butyricum 0-8 per cent. in light mineral oil. More than 95 per cent. of the animals developed joint swelling, which was usually first observed on the 10th day after injection, reached a peak 6 to 8 days after onset, and subsided gradually over a period of a month or more. The number of definitely swollen joints was recorded each day by a technician, without knowledge of the treatment group in which the individual animals were included. An index of peripheral joint swelling was derived as follows:
Number of swollen joints x 10 = Arthritis Score Total number of joints DMN was administered intraperitoneally in saline. Control animals received saline. Several experiments were performed, in which liver, obtained from both normal rats and from rats injected with DMN from 2 to 6 days previously, was homogenized and extracted with cold saline. Extracts were injected into recipient rats within 30 min. of killing the donors. In several experiments plasma for corticosterone determination (Mattingly, 1962) was obtained from cardiac blood between 9 and 10 a.m., within 3 minutes after intraperitoneal injection of pentobarbital.
Results
(1) EFFECT Fig. 2 (overleaf). Effect ofhepatic injury on adjuvant arthritis 473 injection of DMN into the donor rats. Thus, the first injection consisted of extract from a liver removed 2 days after DMN and the second of extract from a liver removed 3 days after DMN. Combined results are shown in Fig. 3 . The use of normal liver extracts produced no alteration in the time of onset or the severity of AA, whereas injection of necrotic liver extracts delayed onset and diminished intensity of arthritis, to a degree comparable with that seen in previous experiments with DMN injection. No effect on intensity of arthritis was seen when half the amount ofDMN-liver extract was used (equivalent to 0 5 g. liver), but the onset and peak ofAA was delayed for approximately 2 days Discussion Clinical observations of patients with rheumatoid arthritis have not led to an understanding of the remission induced by hepatocellular disease andjaundice. The phenomenon does not occur with haemolytic jaundice, nor can it be reproduced by administration of bilirubin (Hench, 1940) . Although some cases have had biliary obstruction, most have had either toxic or virus hepatitis (Hench, 1940) . Deliberate induction of virus hepatitis resulted in a temporary remission, with a mean duration of 40 days, in 25 of 32 patients with rheumatoid arthritis (Gardner, Stewart, and MacCallum, 1945) . It is noteworthy that in several cases improvement in joint symptoms preceded the development of jaundice, an observation also made by Hench (1940) . Although alteration ofendogenous steroid metabolism has been presumed to be the mechanism of remission, this has never been demonstrated directly (Hill and Holley, 1966) . The rate of cortisol conjugation may decrease in acute and chronic liver disease, but this results in diminished ACTH release and a steady state in which cortisol synthesis is reduced and plasma levels are normal (Peterson, 1960) , although diurnal variation of plasma cortisol may be lost (Tucci, Albacete, and Martin, 1966) . In these experiments it was shown that a chemicallyinduced toxic hepatitis could partially inhibit the development of AA. Jaundice did not develop, as was anticipated from other studies in which rats given hepatotoxins demonstrated a remarkable capacity to handle large exogenous bilirubin loads (Krueger and Higginson, 1961) . The timing of liver necrosis was critical, for no inhibition resulted when the toxin was administered too soon, i.e. before adjuvant or within 3 days afterwards, or too late, i.e. within 4 days before the development of overt signs of arthritis. Since various treatments which are thought to inhibit AA through immunosuppression, such as antilymphocyte globulin (Currey and Ziff, 1968) and cyclophosphamide (Brown, Taylor and Pollock, 1971) , are most effective when administered before or soon after adjuvant injection, the response to hepatic necrosis should probably be regarded as an anti-inflammatory effect. The inhibition could be reproduced by injection, at the appropriate time, of necrotic liver extracts, but not by injection of normal liver extracts. This would support the possibility that some anti-inflammatory material released from necrotic liver was responsible for inhibition of AA.
Several alternative explanations may be offered:
(1) DMNmight have a direct anti-inflammatory effect
Suppression of AA by a single dose of any drug given well after induction of the disease by adjuvant would not conform to broad experience with other agents in this system. Our understanding of DMN metabolism would indicate that it should not be present in active form in liver extracts obtained 2 days after administration (Magee and Swann, 1969) , thus failing to account for inhibition of AA by these extracts.
(2) Endogenous corticosteroid release provoked by the stress of hepatic necrosis, or failure of the damaged liver to metabolize corticosteroids could be responsible for the inhibition ofAA The failure to find elevation of plasma corticosterone levels in DMN-injected rats provides some evidence against this mechanism, but definitive experiments using adrenalectomized rats were not attempted because of the high mortality rate after adjuvant injection reported by others (Glenn and Gray, 1965) .
(3) Endotoxin might be the mediator ofAA suppression Animals with severe liver injury are more susceptible to the effects of endotoxin (Farrar and Magnani, 1964) . Although endotoxin may inhibit AA, it does so most effectively when administered before adjuvant injection (Wood and Pearson, 1962) . The role of the liver in the suppression of inflammation has been investigated recently by Billingham, Gordon, and Robinson (1971) . These workers have shown that the liver synthesizes an anti-inflammatory protein which is capable of inhibiting oedema formation, granulation tissue deposition, and delayed hypersensitivity, all of which may play a role in AA. Mielens, Drobeck, Rozitis, and Sansone (1969) have demonstrated inhibition of cotton granuloma and carrageenin oedema in intact and adrenalectomized rats with oral administration of carbon tetrachloride. However, Walz, DiMartino, and Misher (1971) found no modification of AA with the use of this hepatotoxin. McArthur, Dawkins, Smith, and Hamilton (1971) have proposed that certain circulating peptides possess anti-inflammatory properties and that their displacement from serum binding proteins may be an important mode of action of various anti-inflammatory drugs. They measured free and bound serum tryptophan, which, they suggested, may mimic the behavior of anti-inflammatory peptides, and found that free tryptophan was increased in patients with on the fourth or fifth day after adjuvant injection. jaundice and pregnancy as well as in rheumatoid Injection of necrotic liver extracts, but not normal arthritis under treatment with various medications.
liver extracts, also resulted in a similar suppression of Although these observations fall far short of an arthritis. The experiments supported the possibility explanation for the remissions induced by liver disease that release of some anti-inflammatory material from in rheumatoid arthritis, they suggest that release ofan damaged liver might be the mechanism of remission anti-inflammatory material or activator may be a in rheumatoid arthritis patients who develop hepatomechanism worthy of further investigation. cellular disease. 
